Pharmacy Grand Rounds

Guidelines UnCAPed: Updates in the Management of Community Acquired Pneumonia

• ACPE Universal Activity Number (UAN): JA0000238-0000-20-028-L01-P
• Session Type: Knowledge-based
• CE Credits: A maximum of 0.75 contact hour (0.075 CEU) for the following: 
  • AAPA Category 1 CME Credits
  • ACPE
  • AMA PRA Category 1 Credits™
  • ANCC

• Session Fee: Free for Mayo Clinic staff

SESSION LOCATIONS

Live Session: (11:00am - 11:45am CST)
MN-RO-AL-MN-459-MAYO LH

Interactive Video Conference Room(s): 
MN-RO-GO-19-101 BARRETTE LH

Participants may attend by viewing: Live Webcast
Video Recording - access two weeks after session date

COURSE DESCRIPTION

After 12 years without new guidance, the community-acquired pneumonia (CAP) guidelines from the Infectious Disease Society of America were updated in October 2019. This presentation will review pertinent updates and guideline recommendations for the diagnosis and treatment of CAP, as well as the data behind a few controversial topics in the management of CAP that were not addressed by the guideline update.

At the conclusion of this knowledge-based CE session, participants should be able to:

1. Explain key changes in community-acquired pneumonia (CAP) management based on recent guideline updates
2. Review appropriate empiric antibiotic selection for patients presenting with CAP in various settings
3. Discuss clinical controversies in CAP management

Session Announcement

Session Slides

FACULTY INFORMATION

Abby K. Hendricks, PharmD
PGY2 Internal Medicine Pharmacy Resident
Mayo Clinic Hospital - Rochester, MN

Abby received a Doctor of Pharmacy degree from the University of North Carolina Eshelman School of Pharmacy and subsequently completed a PGY1 Pharmacy Residency at Mayo Clinic Hospital – Rochester. She is the current PGY2 Internal Medicine Pharmacy Resident with practice interests in anticoagulation, cardiology, and infectious disease.

DISCLOSURE STATEMENTS

As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program:

The faculty report the following relationships:

• Abby K. Hendricks, PharmD
  • Declares no financial relationships pertinent to this session
  • Declares off-label use of devices and medications will not be discussed during this presentation

Course Director and Planning Committee Members declare no relevant financial relationship(s) pertinent to this session.  Members include:

• Brenda Amaris
• Mary Ellen Cordes, MS, APRN, CNC, NE-BC
• Michael Huckabee, MPAS, PA-C, PhD
• Wayne (Nick) Nicholson, MD, PharmD, BCPS
• Garrett Schramm, PharmD, BCPS
• Lee Skrupky, PharmD, BCPS